- Codony, Sandra
- Pujol, Eugènia
- Pizarro, J.
- Feixas, Ferran
- Valverde,E.
- Loza, María Isabel
- Brea, José Manuel
- Saez, Elena
- Oyarzabal, Julen
- Pineda-Lucena, Antonio
- Pérez, Belén
- Pérez, Concepción
- Rodríguez-Franco, María Isabel
- Leiva, Rosana
- Osuna, Sílvia
- Morissea, Christophe
- Hammock, Bruce D.
- Vázquez-Carrera, Manuel
- Vázquez, Santiago
In vivo pharmacological inhibition of soluble epoxide hydrolase (sEH) reduces inflammatory diseases, including acute pancreatitis (AP). Adamantyl ureas are very potent sEH inhibitors, but the lipophilicity and metabolism of the adamantane group compromise their overall usefulness. Herein, we report that the replacement of a methylene unit of the adamantane group by an oxygen atom increases the solubility, permeability, and stability of three series of urea-based sEH inhibitors. Most of these oxa-analogues are nanomolar inhibitors of both the human and murine sEH. Molecular dynamics simulations rationalize the molecular basis for their activity and suggest that the presence of the oxygen atom on the adamantane scaffold results in active site rearrangements to establish a weak hydrogen bond. The 2-oxaadamantane 22, which has a good solubility, microsomal stability, and selectivity for sEH, was selected for further in vitro and in vivo studies in models of cerulein-induced AP. Both in prophylactic and treatment studies, 22 diminished the overexpression of inflammatory and endoplasmic reticulum stress markers induced by cerulein and reduced the pancreatic damage., This work was funded by the Spanish Ministerio de Economía
Industria y Competitividad (grants SAF2017-82771-R to S.V.,
SAF2015-64146-R, andMICIU/ICTI2017-2020/Referencito M.V.-C.,
RTI2018-093955-B-C21 to M.I.R.-F., PGC2018-102192-B-I00
to S.O. and RTI2018-101032-J-I00 to F.F.), the CaixaImpulse
2015 Programme, the Spain EIT Health (Proof of concept
2016), the European Regional Development Fund (ERDF),the Xunta de Galicia (GRC2014/011 and ED431C2018-21),
the Fundació Bosch i Gimpera, Universitat de Barcelona (F2I
grant), the Generalitat de Catalunya (2017 SGR 106, 2017
SGR 124 and 2017 SGR 1707), the Fundacion Fuentes Dutor ́ ,
the European Research Council (ERC-2015- StG-679001-
NetMoDEzyme to S.O.), and the European Community
(MSCA-IF-2014-EF-661160-MetAccembly to F.F.). S.C. and
E.P. acknowledge PhD fellowships from the Universitat de
Barcelona (APIF grants). E.V. and R.L. thank the Institute of
Biomedicine of the University of Barcelona (IBUB) and the
Spanish Ministerio de Educacion, Cultura y Deporte ́ (FPU
grant), respectively, for PhD grants. Partial support was
provided by NIH-NIEHS River Award R35 ES03443, NIHNIEHS Superfund Program P42 ES004699, NINDS R01
DK107767, and NIDDK R01 DK103616. The content is solely
the responsibility of the authors and does not necessarily
represent the official views of the National Institutes of Health.
We thank Daniel Closa (IIBB−CSIC, Barcelona, Spain) for
advice regarding the histological analyses.